Zolbetuximab Uses, Dosage, Side Effects and more
Zolbetuximab is under investigation in clinical trial NCT01630083 (Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer).
| Trade Name | Zolbetuximab |
| Generic | Zolbetuximab |
| Zolbetuximab Other Names | Zolbetuximab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
